Biotech

All Articles

OS Therapies refiles $6M IPO to cash HER2 medicine, preclinical ADCs

.OS Therapies will provide on the NYSE American inventory substitution this morning by means of a $6...

ALX's fizzling CD47 reaction rate sends sell spiraling down

.ALX Oncology's phase 2 stomach cancer action fee has diminished. After observing its own CD47 block...

Ionis axes eye illness coming from intendeds of Roche-partnered possibility after records dissatisfy

.Another of Ionis Pharmaceuticals' essential midphase readouts has actually fallen short of expectat...

Biogen's CEO stated no dangerous deals in 2023. He prepares to become strong

.While Biogen's pharma peers are actually hunting for late-stage resources with little bit of threat...

Instil refills pipeline in $2B biobucks cope with ImmunOnco

.Instil Biography has been a biotech in search of a pipe after it junked its lead properties over th...

Biogen leaves Denali Alzheimer's collab

.Biogen has restored rights to an early Alzheimer's health condition program to Denali Rehabs, going...

Takeda touches new head people oncology organization-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of notable management hirings, firings as well a...

Vertex, hammered by AATD once again, falls 2 possessions on throw out pile

.Vertex's attempt to deal with an uncommon hereditary health condition has actually attacked yet ano...

Vir increases 3 T-cell engagers from Sanofi, lays off 25% of workers

.Vir Medical's second-quarter earnings report had not been except significant updates. The provider ...

Galapagos stops CAR-T tissue treatment trial over Parkinsonism instance

.Galapagos has actually stopped registration in a test of a BCMA-directed CAR-T cell treatment, push...